Skip to main content
Aaron Broadwell, MD, Rheumatology, Shreveport, LA

AaronWiltonBroadwellMD

Rheumatology Shreveport, LA

Rheumatology and Osteoporosis Specialists

Dr. Broadwell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Broadwell's full profile

Already have an account?

  • Office

    820 Jordan Street
    Suite 201
    Shreveport, LA 71101
    Phone+1 318-221-0399
    Fax+1 318-221-1940

Education & Training

  • Scripps Clinic/Scripps Green Hospital
    Scripps Clinic/Scripps Green HospitalFellowship, Rheumatology, 2010 - 2012
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2007 - 2010
  • Mayo Clinic College of Medicine and Science (Jacksonville)
    Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Internal Medicine, 2010
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - Present
  • LA State Medical License
    LA State Medical License 2012 - 2025
  • FL State Medical License
    FL State Medical License 2008 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology
  • National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

  • Fellow American College of Rheumatology

Publications & Presentations

Press Mentions

  • Community Rheumatology Clinics: Pegloticase Safe & Effective with Any Immunomodulator
    Community Rheumatology Clinics: Pegloticase Safe & Effective with Any ImmunomodulatorNovember 30th, 2021
  • 52-Week AWARE Results Show Efficacy, Safety of Rheumatoid Arthritis Therapies
    52-Week AWARE Results Show Efficacy, Safety of Rheumatoid Arthritis TherapiesSeptember 30th, 2019